Top 20 Biotechnology Startup Investors in Hungary (May 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
FastVentures
VC Fund
|
4 | Hungary, South Korea, United States | Seed, Series A, Series B | Software, Biotechnology, Information Technology | |
|
Delin Ventures
VC Fund
|
3 | United Kingdom, Hungary, United States | Seed, Series A, Series B | Software, Information Technology, Biotechnology | $1.5M–$30M |
|
O2h Ventures
VC Fund
|
2 | United Kingdom, Hungary | Seed, Series A, Pre-Seed | Biotechnology, Health Care, Pharmaceutical | $614k–$6.1M |
|
Accel
VC Fund
|
2 | United States, India, United Kingdom | Series A, Series B, Series C | Software, SaaS, E-Commerce | $3.5M–$110M |
|
XTX Ventures
VC Fund
|
2 | United States, United Kingdom, Israel | Series A, Seed, Series B | Artificial Intelligence, Machine Learning, Software | $1.4M–$21M |
|
Euroventures
VC Fund
|
2 | Hungary, United Kingdom, United States | Series A, Seed | Software, Information Technology, E-Commerce | $536k–$11M |
|
Bonitás Ventures
VC Fund
|
2 | Hungary | Seed, Series A | Information Technology, Education, Software | $236k–$4.3M |
|
PortfoLion Capital Partners
VC Fund
|
2 | Hungary, Poland, Switzerland | Seed, Series A, Series B | Software, Information Technology, Big Data | $429k–$12M |
|
Atlantic Labs
VC Fund
|
2 | Germany, Switzerland, United States | Seed, Series A, Pre-Seed | Health Care, Software, Information Technology | $850k–$27M |
|
Vishal Gulati
Angel
|
1 | United Kingdom, Hungary | Seed, Series A, Series B | Biotechnology, Biopharma, Life Science | |
|
MassMutual Ventures
VC Fund
|
1 | United States, India, Singapore | Series A, Series B, Seed | Software, Financial Services, Information Technology | $2.5M–$40M |
|
European Commission
VC Fund
|
1 | Spain, France, United States | Grant, Seed, Pre-Seed | Software, Biotechnology, Health Care | $54k–$21M |
|
Marton Szoke
Angel
|
1 | Hungary, Switzerland, Czech Republic | Series A, Pre-Seed, Series B | Information Technology, Software, EdTech | $1.7M–$3M |
|
The Vascular Group
VC Fund
|
1 | Hungary | Series A | Medical, Health Care, Biotechnology | |
|
Merck Global Health Innovation Fund
VC Fund
|
1 | United States, Canada, Mexico | Series B, Series C | Health Care, Biotechnology, Medical | $9M–$165M |
|
Texas HALO Fund
VC Fund
|
1 | United States, Canada, Hungary | Seed, Convertible Note, Series A | Health Care, Medical Device, Software | $105k–$10M |
|
Daniel Waterhouse
Angel
|
1 | United Kingdom, Germany, United States | Series A, Series B, Seed | Software, E-Commerce, Mobile | $161k–$33M |
|
Boston Millennia Partners
VC Fund
|
1 | United States, Hungary, Switzerland | Series C, Series B | Health Care, Biotechnology, Software | $5M–$53M |
|
Societe Generale Asset Management
VC Fund
|
1 | France, United States, Germany | Series B, Series A | Biotechnology, Software, Health Care | $1.8M–$54M |
|
Christian Dahlen
Angel
|
1 | United States, Germany, France | Seed, Pre-Seed | Software, Artificial Intelligence, Analytics | $235k–$3.2M |
| Access all 24 investors in Hungary Biotechnology startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
venture capital
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A, Series B
- Geography: Hungary, South Korea, United States
Investor stats
- Total investments: 25
- Lead/follow: no public data
Portfolio highlights
- Iskra — Iskra offers web3 gaming opportunities using blockchain and rewards its stakeholders based on their participation.
- On Vacation — On Vacation is a chat-based concierge service where customers may get help making reservations and getting personalized and optimal tours from travel specialists.
- NextChapter — NextChapter is a digital commerce platform that acquires and operates Coupang and Naver-based online native brands in Korea. NextChapter is backed by BlueRun Ventures/BRV Capital Management, Goodwater Capital, Klim Ventures, Fast Ventures and Sandbox Network.NextChapter was founded in 2021 by Joshua Kwon and Jay Chung and is headquarteredin Seoul, Korea.
We invest in early stage technology businesses and, in exceptional cases, will create them from scratch with outstanding partners. We pride ourselves on being open minded and ready to support ideas orthogonal to consensus views.
Show more...Investment focus
- Industry: Software, Information Technology, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, Hungary, United States
Investor stats
- Total investments: 27
- Round size: Seed $1.5M–$8.6M; Series A $5.3M–$30M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- Umedeor — uMed is a technology platform embedded across a global network of healthcare providers that automates the process of building prospective, protocolized patient registries. This enables sites to participate in dozens of programmes simultaneously without increasing overhead or burden on staff. For life science companies, uMed provides access toregulator quality data, where patients within those datasets can be compliantly re-engaged to support the aims of R&D and post-market teams
- Turbine — Turbine builds a platform to understand the inner mechanisms of cancer, enabling the discovery of novel protein targets, precision biomarkers, and better translation to patients. Turbine uses its proprietary Simulated Cell technology in combination with Artificial Intelligence to build a faster and deeper biological understanding of therapeutictargets or indications, untangling the complexity of cancer.
- Ori Biotech — An innovator in Cell and Gene Therapy with a proprietary, flexible manufacturing platform to enable widespread access to lifesaving treatments
Focused on seeding early stage biotech therapeutics and related AI opportunities. The fund will invest in companies qualifying under EIS and covering novel...
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, Hungary
Investor stats
- Total investments: 23
- Round size: Seed $614k–$3.2M; Pre-Seed $1.7M–$2.5M; Series A $1.8M–$6.1M
- Lead/follow: 39% lead, 61% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- PharmEnable — Designing the next generation of small molecule drugs. Replicating the specificity of biologics in the scalable form of a small molecule.
- Five Alarm Bio — Five Alarm Bio is a drug discovery company. Five Alarm intends to use discoveries to provide secure and efficient remedies for a variety of age-related illnesses and limitations. Five Alarm Bio is creating a small molecule strategy to strengthen the body's defense against aging.
- Pencil Biosciences — Next Generation Genome Editing Tool
First partner to exceptional teams everywhere
Show more...Investment focus
- Industry: Software, SaaS, E-Commerce
- Stage:Series A, Series B, Series C
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1443
- Round size: Series A $3.5M–$28M; Series B $8M–$50M; Series C $10M–$110M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Captain Fresh — Captain Fresh is a freshwater fish and seafood supply chain platform. Captain Fresh is a B2B marketplace leveraging technology to deliver the fastest harvest-to-retail in the industry. The company focuses on aggregating the fragmented retail demand across the country and linking them to the small fishermen and farmers throughout the Indian coast.The company was founded in 2019 and is based in Bengaluru, India.
- Rainforest — Rainforest focuses on providing software platforms for payment processing. Rainforest is headquartered in Atlanta, United States.
- Aaritya Technologies — Because when you trade, we want you to trade like a pro.
XTX Ventures is the venture capital arm of XTX Markets. XTX Markets is a leading, innovation-driven algorithmic trading firm.XTX Ventures focuses on early stage startups (Seed to Series A) applying machine learning and leverages XTX Markets’ deep expertise in ML and financial technology to help grow and enhance those businesses. We are geographyand industry agnostic.
Show more...Investment focus
- Industry: Artificial Intelligence, Machine Learning, Software
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 35
- Round size: Seed $1.4M–$4.1M; Series A $3.5M–$21M; Series B $7.5M–$20M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Swapp — Real estate developers, architects and engineers use Swapp to design buildings in a smart, flexible and efficient process.
- Tallarium — Tallarium - The definitive pre-trade data and analytics platform for OTC energy markets, driven by data science
- BIOS — BIOS Health is unlocking the potential of the nervous system in treating chronic disease by using AI-powered neural interfaces that can automatically read and write neural signals.
Budapest-based Euroventures is one of the longest-established and leading independent private equity and venture capital firms in Central Europe, with a proven ability to achieve international exits over two decades in a fast-changing environment. It has advised or is advising five investment programmes totalling over €180m since 1989, with a focuson funding INNOVATION and GROWTH in Hungary and Central Europe. The investors in Euroventures funds have been international institutional Investors. Euroventures' nearly 50 current and former portfolio companies illustrate the commitment to provide steady support through the cycles of the regional and global economy. Its professional team members have many decades of private equity / venture capital experience between them. Recent investments have targeted growing businesses with innovative technologies in the fields of medtech, big data, security, and IoT among others. Euroventures has had an outstanding track record in supporting its portfolio companies entering global markets. As a result, it has delivered highly successful exits, including IPOs (Vienna, NASDAQ, NYSE) and several dozens of trade sales to international corporations. Euroventures is a founding member of the Hungarian Venture Capital Association and complies with the conduct, governing principles and valuation/reporting guidelines of Invest Europe.
Show more...Investment focus
- Industry: Software, Information Technology, E-Commerce
- Stage:Series A, Seed
- Geography: Hungary, United Kingdom, United States
Investor stats
- Total investments: 25
- Round size: Seed $536k–$2.5M; Series A $536k–$11M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Antavo Enterprise Loyalty Cloud — Antavo is an Enterprise Loyalty Cloud, providing best-in-class technology to manage experience-based, paid, and lifestyle loyalty programs.
- Hunch — Hunch empowers you to automate your creative production and media management, to get performance uplifts faster than ever. Get started now.
- Prefixbox — Prefixbox makes eCommerce search easy. Easy to integrate search modules increase conversion rates and online revenue within weeks.
Bonitás is more than an investor. Our team helps the brave founders to pursue their dreams and build extraordinary companies. We push because we respect. Partnering with Bonitás, founders can benefit from our unmatched network and gain experience in management support. Bonitás is proud that our backed companies also propel great causes.
Show more...Investment focus
- Industry: Information Technology, Education, Software
- Stage:Seed, Series A
- Geography: Hungary
Investor stats
- Total investments: 25
- Round size: Seed $236k–$1.6M; Series A $1.1M–$4.3M
- Lead/follow: 100% lead, 0% follow
- Last fund: May invest from a new fund soon — raised $40M in 2018
Portfolio highlights
- Livlia — As Hungary’s first hybrid real estate service, portal, and ecosystem, Livlia’s goal is to revolutionize the Hungarian and the regional real estate market with their automatized working methods, modern solutions and professional real estate experts. The platform is launching today with the aim of digitalising and revolutionizing and the entire realestate industry.Ads optimization, developed price strategy, pre-identified customers, all of which can be traced on the platform which is complemented by a dedicated real estate expert. As a result of their modern and digitalised solutions and working methods, they thrive working for one of the most competitive success fees (1,5%) within the Hungarian real estate industry offering more, for less.
- MITE-CHEM KFT. — Manufacture of pesticides and other agrochemical products
- Gremon Systems — Digitalize your production with Gremon: discover the highest agricultural IT inventions in crop production, monitoring and evaluation of data. Be the first!
Portfolion is a CEE-focused multi-stage investor with a flexible fund structure that allows it to back companies from or before 1st client until the end of their journey. The fund manager has backed some of the CEE region’s most successful companies including SEON, Novakid, Tresorit, Packhelp, and Starschema.
Show more...Investment focus
- Industry: Software, Information Technology, Big Data
- Stage:Seed, Series A, Series B
- Geography: Hungary, Poland, Switzerland
Investor stats
- Total investments: 58
- Round size: Seed $429k–$7.5M; Series A $1.1M–$5M; Series B $3.8M–$12M
- Lead/follow: 41% lead, 59% follow
- Last fund: May invest from a new fund soon — raised $75M in 2020
Portfolio highlights
- deskbird — Most intuitive and people-centric - deskbird's hybrid workplace solution that employees will love. For all flexibe companies, from startup to corporate.
- Renewabl — Renewabl is the platform that allows companies to meet their decarbonisation targets quickly and efficiently by matching renewable energy certificates directly from hydro, wind and solar on a 24/7-hour basis.
- Commsignia — Commsignia specializes in the research and development, manufacturing and distribution of cooperative intelligent transportation systems. Its product line includes a V2X Communication Software Stack and Commsignia’s own security stack implementation, Hybrid V2X/ADAS Safety Applications, a V2X Simulator, On-Board Units (OBU) and Roadside Units(RSU).The company was founded in 2012 and is headquartered in Santa Clara, California.
Atlantic Labs supports and invests in mission-driven founders working on transformative technology ventures. <br><br>We partner with founders early, providing the capital, tools and network necessary to growing their companies and accompanying them on their entrepreneurial journey. We are currently active in areas including Digital Health, Future of Work, Machine Learning, Decentralized Networks, Mobility and Industrial Applications.
Show more...Investment focus
- Industry: Health Care, Software, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 156
- Round size: Seed $1.1M–$5.6M; Pre-Seed $850k–$1.3M; Series A $4.6M–$27M
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- SureIn — small business insurance manager
- Colonia — Colonia is a logistics company that brings all global trucks and trailers into one shared fleet.
- Purpose Green — Purpose Green operates as a climatetech company.
Vishal Gulati: Vishal serves as a venture partner specialising in digital health at DFJ Esprit, Europe's leading Silicon Valley style venture capital firm with over $1b under management. Since 2012, Vishal has been Europe’s leading promoter of investment into the emerging digital health sector and chairman of Digital Health Forum, whichsupports the best in class digital health companies to grow into global enterprises. Vishal serves on several boards including Horizon Discovery Group PLC (Cambridge, UK), a gene editing company; Fluidics Analytics (Cambridge, UK), a next gen protein discovery engine, Frameshift a healthcare information flow platform (London, UK) and EcoEos (San Francisco, USA), a consumer genomics business. His previous investments include Napo Pharmaceuticals, Glenmark, Renovo and Phagenesis.
Show more...Investment focus
- Industry: Biotechnology, Biopharma, Life Science
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, Hungary
Investor stats
- Total investments: 7
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- Arctoris — Arctoris is a platform company headquartered in Oxford, with its US operations based in Boston and its APAC operations based in Singapore. Arctoris developed and operates a unique drug discovery platform powered by advanced robotics and data science combined with an experienced team of biotech & pharma veterans. Arctoris actively pursuesseveral drug discovery programs in oncology and neuro, while also providing access to its platform to select biotech and pharma partners. Arctoris' approach of data-driven drug discovery leads to higher chance of success, and an accelerated progression of programs towards the clinic.
- evonetix — evonetix is a new spin-out company that is currently incubating in the centre of the world-renowned Cambridge cluster of high-tech and life science organisations. We are seeking to develop and commercialise a new approach to the synthesis of DNA to facilitate the fast-emerging and exciting field of synthetic biology. By employing novel techniqueswe are able to advance DNA synthesis to levels never before seen. Our engineering team has decades of experience developing high integrity automated systems. Our high calibre team brings together expertise from across the scientific and engineering disciplines.
- Turbine — Turbine builds a platform to understand the inner mechanisms of cancer, enabling the discovery of novel protein targets, precision biomarkers, and better translation to patients. Turbine uses its proprietary Simulated Cell technology in combination with Artificial Intelligence to build a faster and deeper biological understanding of therapeutictargets or indications, untangling the complexity of cancer.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!MMV is a multistage, global venture capital firm investing in enterprise software, cybersecurity, financial technology, and digital health companies. We help accelerate the growth of the companies we partner with by providing capital, connections and advice.
Show more...Investment focus
- Industry: Software, Financial Services, Information Technology
- Stage:Series A, Series B, Seed
- Geography: United States, India, Singapore
Investor stats
- Total investments: 98
- Round size: Seed $2.5M–$6.4M; Series A $4M–$23M; Series B $7.5M–$40M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Cardata — Fully-managed vehicle reimbursement programs and software that are transparent, reliable, and efficient, so you save time, money, and headaches.
- Immix — Immix engages in scaling web3 trading through next-generation technologies.
- Rapid Applications Group — Heavy Equipment and Machinery Software: Rapid ERP Systems is used to dispatch and manage more concrete pumping jobs in US & Canada than all other solutions combined.
The official website of the European Commission, providing access to information about its political priorities, policies and services
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Grant, Seed, Pre-Seed
- Geography: Spain, France, United States
Investor stats
- Total investments: 126
- Round size: Seed $55k–$2.8M; Grant $54k–$21M; Pre-Seed $54k–$1.6M
- Lead/follow: 63% lead, 37% follow
- Last fund: May invest from a new fund soon — last raise in 2014
Portfolio highlights
- Vianode — Vianode is a producer of sustainably engineered battery materials.
- Devnya Cement — Devnya Cement is a cement company that operates in the wholesale construction products industry.
- Angelini Pharma — Angelini is committed to identifying health solutions with a prevalent focus on the areas of Central Nervous System (CNS), including pain, and Rare Diseases. The Company is also a leading player in the Consumer Health sector,
An entrepreneur and investor with a business background and solid technical experience. Founded several startups, the latest being Indextools, a software company specializing in enterprise on-demand web analytics software. In April 2008 Indextools got acquired by Yahoo! Inc. At the time of the acquisition, Indextools was recognized as one of thetop five web analytics vendors world-wide by Forrester / Jupiter Research. Mr. Szőke served at Yahoo for three years to lead integration efforts and to realign Indextools’ business model.
Show more...Investment focus
- Industry: Information Technology, Software, EdTech
- Stage:Series A, Pre-Seed, Series B
- Geography: Hungary, Switzerland, Czech Republic
Investor stats
- Total investments: 7
- Round size: Series A $1.7M–$3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Omixon — Omixon is a biotechnology company that specializes in high-resolution HLA genotyping.
- Ydistri — Digital tool for slow moving inventory problem
- Logiscool — International franchise network teaching kids programming
The Vascular Group is a medical practice company that delivers art diagnostic and therapeutic procedures.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Series A
- Geography: Hungary
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- VRG Therapeutics — VRG Therapeutics is a biotechnology company that focuses on miniprotein-based medications and cellular and gene therapy (CGT) technologies.
Merck Global Health Innovation Fund (MGHIF) is a growth investor partnering with innovative digital health and data science companies that facilitate and optimize biopharmaceutical operations with the goal of improving patient care.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series C
- Geography: United States, Canada, Mexico
Investor stats
- Total investments: 88
- Round size: Series B $9M–$58M; Series C $10M–$165M
- Lead/follow: 47% lead, 53% follow
Portfolio highlights
- Pragma Bio — VastBiome is a biotechnology company that mines microbiome drugs to treat cancer and autoimmune disease.The company employs its proprietary methods in genomic sequencing, artificial intelligence, and synthetic biology to discover biomarkers and therapeutics for challenging immunologic disorders. It offers a platform that aims to aggregate publicand private data in order to generate a microbiome database and leverages analytical processes to discover connections between distinct and biologically related data in order to increase statistical power and drive discovery. In addition, the platform can be used to identify novel biomarkers to risk-stratify patients and predict clinical outcomes.It was co-founded by Peter McCaffrey, Kovi Bessoff, Ayin Vala, and Kareem Barghouti in Millbrae, California in 2018.
- AeroSafe Global — AeroSafe Global delivers cold chain solutions to the biopharma industry with zero temperature excursions for every patient, every product, every time.
- Octave — Octave has developed the first of it's kind precision care solution focused on neurodegenerative diseases beginning with Multiple Sclerosis (MS).
Early Stage Venture Investments
Show more...Investment focus
- Industry: Health Care, Medical Device, Software
- Stage:Seed, Convertible Note, Series A
- Geography: United States, Canada, Hungary
Investor stats
- Total investments: 92
- Round size: Seed $105k–$3M; Series A $3M–$10M
- Lead/follow: 9% lead, 91% follow
- Last fund: May invest from a new fund soon — last raise in 2021
Portfolio highlights
- Flourish Collective — FlourishFund is a digital platform that empowers and supports new and expecting families. The platform consists of two parts: a marketplace with evidence-based goods and vetted maternal wellness services and a funding mechanism for friends and families to contribute to a positive birth and parenting journey.
- Drusolv Therapeutics — Drusolv Therapeutics is a clinical-stage drug company developing a novel, high-dose statin for early intervention in age-related macular degeneration. Their product ocustatin is aimed at patients who are still in the intermediate stage of the disease and currently have very limited options to prevent progression to late-stage vision loss. Ocustatinwas developed at Harvard University and has been validated in a very successful proof-of-concept clinical trial that showed a 75% reduction in progression to late-stage blindness. John Edwards, the founder and CEO of Drusolv, is a serial entrepreneur with extensive experience in AMD.
- Vartega — Vartega is a technology development company specializing in the carbon fiber-reinforced plastic recycling process. We have developed alternative technology, processes, and equipment to provide low-cost carbon fiber for use in mass market applications.
Daniel joined Balderton as a General Partner in 2013 and he currently sits on the boards of Revolut, ROLI, Lovecrafts, TrademarkNow, Tictail, Thread, and Workable and also works with Instabridge and Curious.AI.Prior to Balderton, Daniel spent 5 years as a partner at Wellington Partners and invested in a number of fast-growing companiesincluding EyeEm, Hailo, YPlan, Bookatable (also a Balderton portfolio company, sold to Michelin), SumAll, Readmill (sold to Dropbox) and Qype (sold to Yelp).Before Wellington, Daniel was a sector partner at 3i where he worked on all of their venture and private equity investments in the internet sector in North America and Europe.And before that, he was at Yahoo! for six years from 1999, covering strategic development and M&A across the European region. He has a PhD and MA in applied mathematics from Oxford University and a Chartered Diploma in Accounting and Finance.
Show more...Investment focus
- Industry: Software, E-Commerce, Mobile
- Stage:Series A, Series B, Seed
- Geography: United Kingdom, Germany, United States
Investor stats
- Total investments: 66
- Round size: Seed $161k–$7.7M; Series A $3M–$17M; Series B $3.2M–$33M
- Lead/follow: 39% lead, 61% follow
Portfolio highlights
- Mapfit — Mapfit was sunset in October 2018. Please see these 16 Google Places API alternatives.
- Unaric — Unaric buys, builds and grows Salesforce based SaaS companies and is backed by leading global investors.
- Turbine — Turbine builds a platform to understand the inner mechanisms of cancer, enabling the discovery of novel protein targets, precision biomarkers, and better translation to patients. Turbine uses its proprietary Simulated Cell technology in combination with Artificial Intelligence to build a faster and deeper biological understanding of therapeutictargets or indications, untangling the complexity of cancer.
Boston Millennia Partners (BMP) has a long and successful history of growth capital investing on a national scope. Our Core Company Investment Strategy, combined with our international network of relationships and deep industry expertise, sets us apart from other investor groups and enables us to contribute meaningfully to our portfolio companies.The company focuses on investment opportunities within the healthcare and business services industries. Outsourcing and software as a service business companies are of particular interest for investment.Boston Millennia Partners' goal is to be supportive and effective investing partners, and establish productive relationships with its business partners that create long-term value.The company seeks to partner with entrepreneurs who share our goal of building enduring, large-scale businesses that result in personal fulfillment and superior financial returns. Over the past thirty years, it has implemented an investment approach that centers on active participation with our portfolio companies. Its goal is to be supportive and effective investing partners and establish productive relationships with its business partners that create long-term value.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series C, Series B
- Geography: United States, Hungary, Switzerland
Investor stats
- Total investments: 111
- Round size: Series B $5M–$53M; Series C $5.5M–$43M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- CubeWorks — CubeWorks’ mission is to accelerate the future of IoT and build a world connected by ubiquitous sensor technology through millimeter-scale smart sensing solutions. In 2013, following a decade of research on ultra-low-power circuitry at the University of Michigan, CubeWorks was founded to advance the next generation of IoT sensors. Today, with thedevelopment of the CubiSens™ Platform, CubeWorks brings to market a portfolio of ultra-small wireless smart sensors. These sensors offer limitless potential across a broad range of applications and provide access to mission-critical information exactly when and where it is needed.
- KAID Health — KAID Health offers and specializes in artificial intelligence and natural language processing for healthcare organizations. KAID allows providers and payers to collaborate to achieve their individual clinical, operational, and financial goals, including revenue optimization and bending the cost-curve.
- Atropos Health — Atropos Health rapidly provides personalized real-world evidence for any clinical decision
SGAM AI is a leading institutional player in Alternative Investment Management. SGAM AI successfully mixes the cultures of asset management and capital markets. They are client driven and institutional, like an asset manager. Their approach of each market is entrepreneurial and financial, like an investment bank. They offer the widest coverage ofAlternative Investment classes. Their size and profitability allow long term investments and credibility. They have the ability to offer solutions, not only products. SG Group's strengths are brought to the Alternative Investment's industry. They benefit from SG Group's long term commitment in Alternative Investments. They use the processes ans resources of SGAM Group (rated M2 by Fitch).
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Series B, Series A
- Geography: France, United States, Germany
Investor stats
- Total investments: 47
- Round size: Series A $1.8M–$54M; Series B $2.1M–$15M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Augure — Augure by Launchmetrics' software and social data help brands and agencies to bridge the gap between traditional PR and Influencer Marketing. Every day, more than 1,000 Communication, PR, and Public Affairs teams use the Publisher platform to engage relevant influencers, manage their campaigns, improve efficiency and increase their presence inthe media and on social networks.The Augure by Launchmetrics' data services team compliments the Publisher software as the people behind the technology, offering consulting services that help clients to make sense of the data and apply it to their Influencer Marketing strategies.Founded in 2002 in Paris, Augure operates in Europe and Latin America. Its clients include Orange, Thales, AG Insurance, Pierre & Vacances, Château de Versailles, Amalthea, Hill+Knowlton and many others that span across the corporate sector.
- Force-A — FORCE-A designs, produces, and sells optical sensors for the assessment of physiological and health status of crops. It offers crop sensors for nondestructive assessment of leaf polyphenolics. The company also provides multiparameter noncontact sensors-based on leaves or fruits, and berries autofluorescence measurements. Its multiparameternoncontact sensor provides inputs for decision support systems for a range of crops, including fertilisation needs, weed infestation, crop diseases, and crop yield and quality forecast. The company was founded in 2004 and is based in Orsay, France.
- METRIXWARE — Metrixware has, since 1995, been providing software maintenance & quality management solutions to CIOs and IT professionals through its System Code range of application management tools. The company provides global organizations with information, indicators and diagnostic to streamline decision making and implement best practice and compliancestandards.
Christian Dahlen is a business angel. He provides expert capital and venture advice to B2B SW startups in Silicon Valley and in Germany. He is a member of the Band of Angels, Silicon Valley's oldest seed funding organization. Christian was a VP at SAP and held various roles in business strategy and operations. Prior to SAP, he was theGeneral Manager for the Internet and phone business of Kabel Deutschland (KDG), Germany's largest cable operator. He joined KDG from Excite@Home, and before that was with McKinsey & Co.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Analytics
- Stage:Seed, Pre-Seed
- Geography: United States, Germany, France
Investor stats
- Total investments: 39
- Round size: Seed $1.3M–$3.2M; Pre-Seed $235k–$1.2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Deltia — We use computer vision and AI analytics to provide insights into manual assembly processes - our platform supports process engineers in driving productivity and quality of assembly processes
- Alphadoc — Interactive documentation that converts. Explain APIs and SDKs in a single environment. Keep your docs in sync, reuse content, powerful AI, and more
- comstruct — comstruct is working on a platform that will allow construction companies to digitize and automate material purchasing. All delivery bills, invoices, and purchase orders, as well as processes such as invoice verification, can be exchanged digitally with suppliers. All data pertaining to the purchasing process is made available for documentation,evaluation, and process optimization.
Biotechnology Investor funding in Hungary at a glance
Stats across 22 deals from 24 investors.
Access all 24 investors in Hungary Biotechnology startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotechnology Investors in Hungary investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 24 investors investing in Hungary Biotechnology startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!